Clinical trials of new generation AIDS vaccines

According to world scientists, a new generation of vaccines can trick the HIV virus, which could be tested clinically next year.

The new vaccine could adapt to the continuous mutation of the HIV virus.

The rapid growth of HIV virus mutations has made current drugs not work much.

Illustration.

HIV virus is mainly composed of protein and can cause AIDS, destroy human immune system, making patients susceptible to infectious diseases and cancer.

Traditional anti-AIDS vaccines through stimulating human body immune system to identify specific amino acids in HIV virus.

However, the new generation vaccine is made up of many types of artificial proteins arranged through computer systems. This new generation vaccine will invade the human body's immune system and react to many strains of HIV virus.

Scientists hope to conduct clinical trials on this new generation of AIDS vaccines in 2012. The study was funded by the Bill & Melinda Gates Foundation and the National Health Research Institute. America